2002 Publications

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |

Askenova, M., Butterfield, D.A., Zhang, S.-X., Underwood, W. and Geddes, J.W. Increased protein oxidation and decreased creatine kinase BB expression and activity following spinal cord contusion injury. J. Neurotrauma 19: 491-502, 2002.

Bu, J., Bruckner, S.R., Sengoku, T., Geddes, J.W., and Estus, S. Glutamate regulates caveolin expression in rat hippocampal neurons. J. Neurosci. Res.

Chouthai, N.S., J. Sampers, N. Desai, and G. M. Smith, Changes in Neurotrophin Levels in Umbilical Cord Blood from Babies with Different Gestational Age and Clinical Conditions. Pediatric Research.

Hall, E.D. Acute treatment strategies for spinal cord injury. Chapter 59 in: Spinal Cord Medicine: Principles and Practice (V.W. Lin et al., eds.); Demos, N.Y., 2002, pp.777-784.

Hostettler ME, Knapp PE and Carlson SL (2002). Platelet activating factor induces caspase-3 dependent apoptosis in astrocytes and oligodendrocytes in vitro. Glia, 38:228-239.

Hynds D. L. and Snow D. M. A semi-automated image analysis method to quantify neurite preference/axon guidance on a patterned substratum. J. Neurosci. Methods 121(1):53-64.

Hynds, D. L., Inokuchi, J-i, and Snow, D.M. (2002) L- and D- threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) inhibit neurite outgrowth from SH-SY5Y cells. Neuroscience 114(3):731-744.

Karpuj , M.V., Becher, M.W., Springer, J.E., Chabas, D., Pedotti, R., and Steinman, L. Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease with administration of the transglutaminase inhibitor cystamine. Nature Medicine, 8(2):143-149, 2002.

Knapp PE and Adams MA. Epidermal growth factor promotes oligodendrocyte differentiation and enhances survival and regrowth after injury. Exp. Cell Res.

Kupina, N.C., M.R. Detloff, W.F. Bobrowski, B.J. Snyder and E.D. Hall. Cytoskeletal protein degradation and neurodegeneration evolves differently in males and females following experimental head injury. Exp. Neurol.

Kupina, N.C., M.R. Detloff, S. Dutta and E.D. Hall. The Neuroimmunophilin ligand V-10,367 is neuroprotective following 24-h delayed administration in a mouse model of diffuse traumatic brain injury. J. Cereb. Blood Flow & Metab. 22:1212-1221, 2002.

La Fontaine, M., Geddes, J.W., and Butterfield, D.M. 3-Nitropropionic acid-induced changes in bilayer fluidity in synaptosomal membranes: Implications for Huntington’s disease. Neurochem. Res. 27: 507-511, 2002.

McCullers, D.L., Sullivan, P.G., Scheff, S.W. and Herman, J.P. Mifepristone protects CA1 hippocampal neurons following traumatic brain injury in rats. Neuroscience 2002, 109:219-230 (January).

McCullers, D.L. Sullivan, P.G., Scheff, S.W. and Herman, J.P. Traumatic brain injury regulates adrenocorticosteroid receptor mRNA in rat hippocampus. Brain Research 2002, 947:41-9. (August).

Mu, X., Azbill, R.D., and Springer, J.E. Treatment with NBQX improves mitochondrial function and reduces oxidative events after traumatic spinal cord injury. J. Neurotrauma 19(8):917-927, 2002.

Nasr. P., Gursahani, H.I., Pang, Z., Bondada, V., Lee, J, Hadley, R.W. and Geddes, J.W. Influence of cytosolic and mitochondrial Ca2+, ATP, mitochondrial membrane potential, and calpain activity on the mechanism of neuron death induced by 3-nitropropionic acid. Neurochemistry International.

Ngo T.B., P.J. Waggoner, A.A. Romero, R.C. Eberhart, K.D. Nelson, and G.M. Smith. Bioresorbable microfilaments enhance axonal regeneration across a sciatic nerve lesion. J. Neurosci. Res.

Narayan, R.K., M.E. Michel, B. Ansell, A. Baethmann, A. Biegon, M.B. Bracken, M.R. Bullock, S.C. Choi, G.L. Clifton, C.F. Contant, W.M. Coplin, W.D. Dietrich, J. Ghajar, S.M. Grady, R.G. Grossman, E.D. Hall, W. Heetderks, D.A. Hovda, J. Jallo, R.L. Katz, N. Knoller, P.M. Kochanek, A.I. Maas, J. Majde, D.W. Marion, A. Marmarou, L.F. Marshall, T.K. McIntosh, E. Miller, N. Mohberg, J.P. Muizelaar, L.H. Pitts, P. Quinn, G. Riesenfeld, C.S. Robertson, K.I. Strauss, G. Teasdale, N. Temkin, R. Tuma, C. Wade, M.D. Walker, M. Weinrich, J. Whyte, J. Wilberger, A. B. Young and L. Yurkiewicz. Clinical Trials in Head Injury. J. Neurotrauma 19:503-557, 2002.

Nottingham SA, Knapp PE, Springer JE (2002). FK506 treatment inhibits caspase-3 activation and promotes oligodendroglial survival following traumatic spinal cord injury. Exp. Neurol., 177:242-251.

Rabchevsky, A.G., Fugaccia, I., Sullivan, P.G., Blades, D.A., Scheff, S.W., (2002). Efficacy of Methylprednisolone Therapy for the Injured Rat Spinal Cord. Journal of Neuroscience Research, 68(1), 7-18.

Rabchevsky, A.G. (2002) Influences of activated microglia/brain macrophages on spinal cord injury and regeneration. In: Microglia in the regenerating and degenerating central nervous system. Streit W.J. (ed.), Springer-Verlag: New York. pp. 209-226.

Roof, R.L. and E.D. Hall. Gender Differences in Acute Cerebral Ischemia: Neuroprotective Mechanisms of Estrogen. In: New Concepts in Cerebral Ischemia, R. Lin (ed.), CRC Press, pp. 1-30.

Roof, Robin and E.D. Hall. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J. Neurotrauma 17:367-388, 2002.

Scheff, S.W., Rabchevsky, A.G., Fugaccia, I., Main, J. and Lumpp, J. Experimental modeling of spinal cord injury: Characterization of a force-defined injury device. Journal of Neurotrauma 2002.

Scheff, S.W., Saucier, D.A., and Cain, M.E. A statistical method for analyzing rating scale data: The BBB locomotor score. Journal of Neurotrauma 2002, 19:1251-1260.

Snow, D. M., Smith, J.D., and. Gurwell, J. A. (2002), Binding characteristics of chondroitin sulfate proteoglycans and laminin-1, and correlative neurite outgrowth behaviors in a standard tissue culture choice assay. J. Neurobiol 51:285-301.

Snow, D.M., Smith, J.D., Cunningham, A., McFarlin, and Goshorn E.C. Neurite elongation on chondroitin sulfate proteoglycan is characterized by axonal fasciculation. Exp. Neurol. Springer, J.E. Apoptotic cell death following traumatic injury to the central nervous system. J. Biochem. and Molec. Bio. 35(1):94-105, 2002.

Sullivan P.G., Rabchevsky A.G., Keller J.N., Lovell M.A. and Scheff S.W. Intrinsic differences in isolated brain and spinal cord mitochondria: implication for therapeutic interventions following injury.

Sullivan, P.G., Keller, J.N., Bussen, W.L., Scheff, S.W., (2002). Cytochrome C Release and Caspase Activation after Traumatic Brain Injury. Brain Research, 949, 88-96.

Sullivan, P.G., Dorenbos, K.A., Steward, P, Baram, T.Z. Mitochondrial uncoupling protein-mediated neuroprotection against excitotoxicity. Ann. Neurol.

Szebenyi G, G.M. Smith, P.Li, S.T. Brady. (2002) Levels of neurofilament heavy chain expressed from tetracycline-inducible adenoviral construct modulate intermediate filament structure and cell function. J.Neurosci. Res. (68:185-198).

Thompson, J.S., Brown, S.A., Khurdayan, V., Zeynalzadedan, A., Sullivan, P.G., Scheff, S.W., (2002). Early effects of Tribromoethanol, Ketamine/xylazine, Pentobarbital, and Isoflurane Anesthesia on Hepatic and Lymphoid Tissue in ICR Mice. Comparative Medicine, 52(1), 63-67.

Verbois, S.L, Scheff, S.W., and Pauly, J.R. Time-dependent changes in rat brain cholinergic receptor expression following experimental brain injury. Journal of Neurotrauma 2002, 19:1569-1585.

Verbois, S.L, Scheff, S.W., and Pauly, J.R. Chronic nicotine treatment attenuates a7 nicotine receptor deficits following traumatic brain injury. Neuropharmacology 2002.

Verbois, S.L., Hopkins, D.M., Scheff, S.W., and Pauly, J.R. Chronic intermittent nicotine administration attenuates traumatic brain injury induced cognitive dysfunction. Neuroscience 2002.

Zhang, S.-X., Bondada, V., and Geddes, J.W. Evaluation of conditions for calpain inhibition in the rat spinal cord: effective postinjury inhibition with intraspinal MDL28170 microinjection. J. Neurotrauma.

Back to top